CT心肌灌注成像:是否已可常规临床应用?
本文讨论CT心肌灌注成像(CT-MPI)在冠心病评估中的价值。CT-MPI可在CCTA基础上提高对缺血的特异性诊断和预后价值,可定量心肌血流量并计算冠脉血流储备,与15O-H2O PET及有创FFR相关性好,患者偏好CCTA/CT-MPI检查。但CT-MPI用于识别非阻塞性/微血管病变所致缺血的临床效用尚待确立。
要点
- CT-MPI可提高CCTA对病变特异性缺血的阳性预测值。
- CT-MPI在CCTA基础上对主要不良心脏事件提供增量预后价值。
- CT-MPI与15O-H2O PET相关性好,患者对CCTA/CT-MPI满意度高。
核心结论
- CT-MPI已可用于检测阻塞性病变所致心肌缺血,但用于识别非阻塞性/微血管病变缺血的临床效用尚待确立。
临床应用与阅片要点
- CT-MPI可在CCTA基础上增加对病变特异性缺血的诊断和预后价值。
- CT-MPI可定量心肌血流量并计算冠脉血流储备,与15O-H2O PET及有创FFR相关性好。
- 患者对CCTA/CT-MPI的总体满意度高于SPECT、MRI和有创冠状动脉造影。
局限性
- CT-MPI用于识别非阻塞性/微血管病变所致缺血的临床效用尚待确立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
UNLABELLED: The detection of functional coronary artery stenosis with coronary CT angiography (CCTA) is suboptimal. Additional CT myocardial perfusion imaging (CT-MPI) may be helpful to identify patients with myocardial ischaemia in whom coronary revascularization therapy would be beneficial. CT-MPI adds incremental diagnostic and prognostic value over obstructive disease on CCTA. It allows for the quantitation of myocardial blood flow and calculation of coronary flow reserve and shows good correlation with 15O-H2O positron emission tomography and invasive fractional flow reserve. In addition, patients prefer CCTA/CT-MPI over SPECT, MRI and invasive coronary angiography. CT-MPI is ready for clinical use for detecting myocardial ischaemia caused by obstructive disease. Nevertheless, the clinical utility of CT-MPI to identify ischaemia in patients with non-obstructive/microvascular disease still has to be established.
KEY POINTS: • CT-MPI can improve the positive predictive value of CCTA for lesion-specific ischaemia. • CT-MPI adds incremental prognostic value over CCTA for major adverse cardiac events. • CT-MPI correlates with 15 O-H 2 O PET. • CT-MPI/CCTA shows high overall patient satisfaction.
引用
- Takx RAP, Celeng C, Schoepf UJ, et al. CT myocardial perfusion imaging: ready for prime time? Eur Radiol. 2017. PMID: 28956115. doi:10.1007/s00330-017-5057-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。